lobbying_activities: 3070884

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3070884	c286a1a3-6674-496a-b880-04be9f8bf743	Q3	AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.	288670	AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC	2023	third_quarter	TOB	Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act, including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; The Quit Because of COVID-19 Act (Helping Tobacco Users Quit Act) The PROTECT Act Increasing Access to Lung Cancer Screening Act (H.R. 4286) Helping Tobacco Users Quit Act (H.R. 4775) Tobacco Tax Equity Act of 2023 (H.R. 5715/S. 2929)	Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office		2060000	0	0	2023-10-20T10:46:47-04:00